Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hypertrophic cardiomyopathy with persistent ST segment elevation simulating acute myocardial infarction

F Luzza¹, S Carerj, G Oreto

¹francescoluzza@tiscali.it

Heart (British Cardiac Society)

|March 17, 2004

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quality of endoscopic screening for colorectal cancer in Italy: A national survey.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2022

Same author

The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study.

Frontiers in medicine·2022

Same author

The role of gluten-free diet in nonalcoholic fatty liver disease development.

European review for medical and pharmacological sciences·2021

Same author

Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.

European review for medical and pharmacological sciences·2021

Same author

Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study.

European review for medical and pharmacological sciences·2021

Same author

Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.

European review for medical and pharmacological sciences·2021